Home – PTX Therapeutics2018-08-30T23:13:24+00:00

Novel cancer therapies targeting key cancer pathways

READ MORE
Prescient Therapeutics PTX

We are a clinical stage oncology company developing novel drugs
that show great promise as potential new therapies to treat a range of cancers.

prescient therapeutics

OUR COMPANY

Prescient Therapeutics’ novel compounds inhibit key tumor survival pathways, inhibiting cancer growth and overcoming resistance to prior therapies.

Digital Brochure

Two Page Fact Sheet

prescient therapeutics

OUR SCIENCE

Our technologies emanate from renowned institutions Yale University and the Moffitt Cancer Center and are backed by a myriad of peer review publications.

prescient therapeutics

LATEST NEWS

31/10/18September 2018 Appendix 4C - QuarterlyPDF
29/10/2018PTX Appoints Former Array BioPharma Executive to Key RolePDF
19/10/2018Notice of Annual General Meeting/Proxy FormPDF
17/10/2018Pipeline Collaboration fir Next Generation FormulationsPDF
24/09/2018Canadian Patent Granted for PTX-200PDF
05/09/2018Rodman & Renshaw Global Investment Conference PresentationPDF